Immune Signatures May Predict Adverse Events in Patients Taking Immunotherapy

A study by researchers from the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have identified distinct immune “signatures” in patients who develop adverse events while taking immunotherapy for cancer. This may help oncologists identify patients at serious risk for immunotherapy-related side effects.

LEARN MORE

SEE ALL NEWS

Recent Posts

Why There *Still* Isn’t a Routine Screening Exam for Ovarian Cancer Instruments of Healing Five-Year Analysis Shows Immunotherapy Plus Chemotherapy Before Lung Cancer Surgery Significantly Improves Long-Term Survival Johns Hopkins Medicine Sparks Hope, Confidence for Woman with Rare Head and Neck Cancer Combining Laboratory Techniques Yields Wealth of Information About Deadly Brain Tumors Fluorescent Imaging Breakthrough Helps Johns Hopkins Surgeons Target Hidden Lung Tumors Cal Ripken Jr.’s Prostate Cancer Journey How women are beating gynecological cancers Sunscreen and Your Morning Routine